Since it was signed into law in 2022, the health industry has been abuzz about the longer-term impact of the Inflation Reduction Act. In this episode, Jen and Mindy sit down to discuss recent headlines and developments around this landmark legis

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the ruling by Alabama’s Supreme Court that frozen embryos can be legally regarded as “extrauterine children” under state law, and the impact this decision has had on

In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, covering a prominent oncology society\’s push for tumor classification reform that could have profound impacts on cancer survival rates, the critical need f

Over the last few years, the MedTech market has been navigating an unpredictable environment due to macro-economic factors and pandemic-driven activity. As we start off 2024, there’s a prevailing feeling that this market is finally starting to sta

In this episode, Jen sits down with Vynamic’s Deal Activation and Partnership Enablement Service Leads, Senior Director Kevin Fletcher and Executive Sean Martin, to discuss recent newsworthy items coming out of the J.P. Morgan Healthcare Confere

Within Life Sciences companies, Medical Affairs teams are tasked with gathering and communicating scientific data, a job that has only grown in importance as therapies have grown more complex and stakeholders have multiplied. Stretched in many dir

In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, including the potential impact of Wegovy in reducing excess deaths in the UK, a groundbreaking report on minimising the environmental footprint of surgical

The US Pharmacy Industry is the largest in the world, with many different players involved in ensuring pharmaceutical products reach consumers. These channels and distribution outlets have drastically changed over the years and will only continue

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the announcement that Bristol Myers Squibb is purchasing RayzeBio, the use of artificial intelligence in discovering antibiotics that stop MRSA infections, and recent

In this special episode, we conclude our annual series on the biggest health industry trends of the next year. Jen sits down with Vynamic Senior Executives Karen Baldry, Mindy McGrath, and Ryan Hummel, and Executives Mary Virzi and Saurabh Raman t